Start: April 1, 2019
End: August 31, 2023
This study will evaluate the long-term effects of a treatment using light on cognition, sleep, and metabolism in people with mild cognitive impairment (MCI), mild Alzheimer's disease, or a related dementia. Participants will be randomly assigned to receive either a tailored light intervention or a placebo treatment at home for six months. The intervention will provide daily stimulation with bluish-white (experimental) or yellow-white (control) light sources that are tuned to the sensitivity of the circadian system, which controls the human sleep-wake cycle. Researchers will measure if the intervention can reduce sleep disturbances, inflammation, insulin sensitivity, and improve glucose metabolism and cognition.
Minimum Age: 55 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
New Brunswick, NJ 08854
RecruitingChristoph Buettner, MD
Icahn School of Medicine at Mount Sinai
New York, NY 10029
RecruitingChristoph Buettner, MD, PhD
Lead: Rensselaer Polytechnic Institute
Source: ClinicalTrials.gov ID: NCT03933696